Come up with a name for your new list and we'll add to it:
ACCUM Therapeutics raised a round of funding on July 28, 2017. Investors include
Woden Venture Capital Corporation.
ACCUM Therapeutics is a biotechnology research and development company that aims to enhance the delivery of tumor-specific therapeutic drugs.…